Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Basic toxicokinetics

Currently viewing:

Administrative data

Endpoint:
basic toxicokinetics, other
Type of information:
(Q)SAR
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
results derived from a valid (Q)SAR model and falling into its applicability domain, with limited documentation / justification
Justification for type of information:
1. SOFTWARE
ADMETlab 2.0

2. MODEL (incl. version number)
ADMETlab 2.0

3. SMILES OR OTHER IDENTIFIERS USED AS INPUT FOR THE MODEL
SMILES: O1C(=O)OC(C1)C=C

4. SCIENTIFIC VALIDITY OF THE (Q)SAR MODEL
[[Explain how the model fulfils the OECD principles for (Q)SAR model validation. Consider attaching the QMRF and/or QPRF or providing a link]
- Defined endpoint:
1) Absorption:
Caco-2 Permeability, MDCK Permeability, Pgp-inhibitor, Pgp-substrate, HIA, F20%, F30%
2) Distribution:
PPB, VD, BBB Penetration, Fu
3) Metabolism:
CYP 1A2 / 2C19 / 2C9 / 2D6 / 3A4 inhibitor, CYP 1A2 / 2C19 /2C9 / 2D6 / 3A4 substrate
4) Excretion
CL, T1/2

- Unambiguous algorithm:
Multi-task graph attention (MGA) framework

- Defined domain of applicability:

- Appropriate measures of goodness-of-fit and robustness and predictivity:
Please see the attachment "ADMETlab 2.0_an integrated online platform for accurate and comprehensive predictions of ADMET properties" Table 1 and Table 2.

- Mechanistic interpretation:
Please see the attachment "ADMETlab 2.0_an integrated online platform for accurate and comprehensive predictions of ADMET properties"

5. APPLICABILITY DOMAIN
[Explain how the substance falls within the applicability domain of the model]
- Descriptor domain:
- Structural domain:
- Mechanistic domain:
- Similarity with analogues in the training set:
- Other considerations (as appropriate):

6. ADEQUACY OF THE RESULT
[Explain how the prediction fits the purpose of classification and labelling and/or risk assessment]

Data source

Reference
Reference Type:
other: QSAR
Title:
Unnamed
Year:
2022

Materials and methods

Test material

Constituent 1
Chemical structure
Reference substance name:
Vinyl ethylene carbonate
EC Number:
700-261-7
Cas Number:
4427-96-7
Molecular formula:
C5H6O3
IUPAC Name:
Vinyl ethylene carbonate
Test material form:
liquid
Specific details on test material used for the study:
SMILES: O1C(=O)OC(C1)C=C

Results and discussion

Applicant's summary and conclusion

Executive summary:

 













































































































































































ADMEProfilesPredicted resultsUnitInterpretation
AbsorptionPgp-inh0.0-Non-inhibitor
 Pgp-sub0.001-Non-substrate
 HIA0.004-The predicted human intestinal absorption is more than 30%.
 F(20%)0.038-The predicted human oral bioavailability is more than 20%.
 F(30%)0.949-The predicted human oral bioavailability is less than 30%.
 Caco-2-4.543log cm/sThe predicted Caco-2 permeability is excellent (> -5.15 log cm/s).
 MDCK0.00018cm/sThe predicted MDCK permeability is excellent (> 2E-05 cm/s).
DistributionBBB0.998-The predicted of BBB penetration is more than 0.1 cm/s (BBB+).
 PPB28.06%-The predicted Plasma protein binding is excellent (<= 90%).
 VD0.659L/kgThe predicted Volume Distribution is excellent (0.04-20 L/kg).
 Fu73.60%-The predicted Fraction unbound in plasms is > 20% (High Fu).
MetabolismCYP1A2-inh0.089-Non-inhibitor
 CYP1A2-sub0.298-Non-substrate
 CYP2C19-inh0.057-Non-inhibitor
 CYP2C19-sub0.645-Non-substrate
 CYP2C9-inh0.011-Non-inhibitor
 CYP2C9-sub0.152-Non-substrate
 CYP2D6-inh0.008-Non-inhibitor
 CYP2D6-sub0.611-Non-substrate
 CYP3A4-inh0.132-Non-inhibitor
 CYP3A4-sub0.314-Non-substrate
ExcretionCL8.31ml/min/kgThe clearance of target chemical is moderate clearance (5-15 ml/min/kg).
 T1/20.848-The predicted T1/2 > 3h